Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine-Reference-Cited by-同舟云学术

Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine

Published:2007-07 Issue:7 Volume:1773 Page:1095-1106
ISSN:0167-4889
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Author:

Donadelli Massimo,Costanzo Chiara,Beghelli Stefania,Scupoli Maria Teresa,Dandrea Mario,Bonora Antonio,Piacentini Paolo,Budillon Alfredo,Caraglia Michele,Scarpa Aldo,Palmieri Marta

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference44 articles.

1. Pancreatic cancer;Li;Lancet,2004

2. Adjuvant therapy in pancreatic cancer: historical and current perspectives;Neoptolemos;Ann. Oncol.,2003

3. New perspectives in the management of pancreas cancer;Haller;Semin. Oncol.,2003

4. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J. Clin. Oncol.,1997

5. The role of membrane transporters in cellular resistance to anticancer nucleoside drugs;Clarke;Cancer Treat. Res.,2002

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GFPT2 expression is induced by gemcitabine administration and enhances invasion by activating the hexosamine biosynthetic pathway in pancreatic cancer;Clinical & Experimental Metastasis;2024-06-18

2. Synergistic therapeutics: Co-targeting histone deacetylases and ribonucleotide reductase for enhanced cancer treatment;European Journal of Medicinal Chemistry;2024-04

3. Gemcitabine resistance in non‐small cell lung cancer is mediated through activation of the PI3K/AKT/NF‐κB pathway and suppression of ERK signaling by reactive oxygen species;Journal of Biochemical and Molecular Toxicology;2023-08-11

4. Photodynamic therapy induced cell cycle arrest and cancer cell synchronization: review;Frontiers in Oncology;2023-07-12

5. Therapeutic efficacy of a MMAE-based anti-DR5 drug conjugate Oba01 in preclinical models of pancreatic cancer;Cell Death & Disease;2023-04-29